Toru Asano - Concepedia

Author

Toru Asano

Tokyo Metropolitan Bokutoh Hospital

Also Known As

Atsushi Hiraoka, T ASANO, T Asano, T Kawazoe, T. Asano, Toru ASANO, Toru Asano

118

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

Tokyo Metropolitan Bokutoh Hospital Jikei University School of Medicine Nippon Medical School Shinmatsudo Central General Hospital Chiba Hokusou Hospital

About

Toru Asano is an author at Tokyo Metropolitan Bokutoh Hospital specializing in medicine, engineering, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	282
2	Engineering	6	6	164
3	Natural Sciences	5	5	162
4	Applied Physics	5	5	109
5	Public Health	1	1	29

Toru Asano

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
A novel “patient‐like” model of cholangiocarcinoma progression based on bile duct inoculation of tumorigenic rat cholangiocyte cell lines†‡ Alphonse E. Sirica, Zichen Zhang, Guan‐Hua Lai, Hepatology	2007	82
Expressions of cyclooxygenase-2 and prostaglandin E-receptors in carcinoma of the gallbladder: crucial role of arachidonate metabolism in tumor growth and progression. Toru Asano, Junichi Shoda, Tetsuya Ueda, PubMed Gallbladder CarcinomaCox-2 MrnaChemoprevention StrategyBiochemistryGastrointestinal Oncology	2002	72
Do More Electrophilic Aldehydes/Ketones Exhibit Higher Reactivity toward Nucleophiles in the Presence of Lewis Acids? Naoki Asao, Toru Asano, Yoshinori Yamamoto Angewandte Chemie International Edition EngineeringBiochemistryNatural SciencesLewis AcidsOrganic Chemistry	2001	55
Chelation Control through the Coordination of Lewis Acids to an Acetylenic π-Bond Naoki Asao, Toru Asano, Takeshi Ohishi, Journal of the American Chemical Society Molecular SciencesAcetylenic π-BondBiochemistryDonut IconNatural Sciences	2000	55
Efficacy and safety of ombitasvir/paritaprevir/ritonavir in dialysis patients with genotype 1b chronic hepatitis C Masanori Atsukawa, Akihito Tsubota, Yohei Koushima, Hepatology Research	2017	45
Short and Long-Term Outcomes of Diabetes Mellitus in Patients with Autoimmune Pancreatitis after Steroid Therapy Yuji Miyamoto, Terumi Kamisawa, Taku Tabata, Gut and Liver	2012	42
Secretory Low-Molecular–Weight Phospholipases A2 and Their Specific Receptor in Bile Ducts of Patients With Intrahepatic Calculi: Factors of Chronic Proliferative Cholangitis Junichi Shoda, Masahito Kano, Toru Asano, Hepatology	1999	42
Identification, Synthesis, and Biological Evaluation of 6-[(6<i>R</i>)-2-(4-Fluorophenyl)-6-(hydroxymethyl)-4,5,6,7-tetrahydropyrazolo[1,5-<i>a</i>]pyrimidin-3-yl]-2-(2-methylphenyl)pyridazin-3(2<i>H</i>)-one (AS1940477), a Potent p38 MAP Kinase Inhibitor Toru Asano, Hitoshi Yamazaki, Chiyoshi Kasahara, Journal of Medicinal Chemistry	2012	41
Design, Synthesis, and Biological Evaluation of Aminoboronic Acids as Growth‐Factor Receptor Inhibitors of EGFR and VEGFR‐1 Tyrosine Kinases Toru Asano, Hiroyuki Nakamura, Yoshimasa Uehara, ChemBioChem	2004	40
Effects of long-term ursodeoxycholate administration on expression levels of secretory low-molecular-weight phospholipases A and mucin genes in gallbladders and biliary composition in patients with multiple cholesterol stones Masahito Kano, Junichi Shoda, Tatsuro Irimura, Hepatology Multiple Cholesterol StonesGastroenterologyPathologyCholangiopathiesOxidative Stress	1998	34

Page 1